6-K ·Filed Sep 25, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor the upcoming Notice of Meeting for any shareholder proposals or director election contests. No immediate trading catalyst from this filing.
Latest settled — T+20d
ATHE ▼ -43.05% at T+20d
NEUTRAL call -43.05% · α vs SPY -41.58% · entry $3.67 → $2.09
T+1d
-4.63%
call -4.63% · α -3.89%
$3.50
settled 4w ago
T+5d
-5.99%
call -5.99% · α -5.77%
$3.45
settled 26d ago
T+20d
-43.05%
call -43.05% · α -41.58%
$2.09
settled 5d ago
T+60d
Pending
in 8w
Price Chart
Loading chart...
Executive Summary
Alterity Therapeutics filed a routine 6-K announcing the date of its 2026 Annual General Meeting (November 20, 2026) and the deadline for director nominations (October 2, 2026). This is an administrative procedural filing with no new financial, operational, or clinical data.
Key Facts
- AGM scheduled for November 20, 2026 at 11:00am AEDT
- Director nomination deadline is October 2, 2026 at 5:00pm AEST
- No financial results, clinical updates, or material agreements disclosed
Financial Impact
No financial impact — purely procedural announcement
Risk Factors
- No material risks identified from this filing
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-031171 |
| Exhibit: ex_1019647.htm | 0001437749-26-031171 |
| Document: 0001437749-26-031171-index-headers.html | 0001437749-26-031171 |
| Document: 0001437749-26-031171-index.html | 0001437749-26-031171 |
| Document: 0001437749-26-031171.txt | 0001437749-26-031171 |
42 reports for ATHE
67% Hit rate @ T+60 Went positive at some point 10 of 10 best @ T+20▲ +27.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (−2.39%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (+2.39%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.14 (+2.39%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.14 (−10.46%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.14 (−10.46%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.14 (−11.93%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.14 (−31.41%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.14 (−33.54%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.14 (−33.54%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.14 (−41.69%) |
Showing 10 of 42
US Market Status
Market Closed — Opens Thu (10h 49m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers